Skip to content
Starmeric®
  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • About Sabinsa
  • Privacy Policy
  • Newsroom
    • Press Releases
    • Sabinsa Stages Food Demo of GRAS Ingredients At NPA Marketplace Trade Show
    • Sabinsa Receives Seven New Patents: Global Patent Portfolio Increased To 87 IP Protection Program Strengthened
    • Sabinsa’s Saberry® + Cococin™ Formulation Granted US Patent
    • Sabinsa To Exhibit At New York Society Of Chemists Suppliers’ Day Show
    • Sabinsa Awarded Four New International Patents
    • Sami–Sabinsa Honored by Associated Chambers of Commerce & Industry of India for Beauty, Wellness & Personal Care
    • FAQ’s
    • Sabinsa Corporation Stages Functional Food Demo At Expo West
    • Sabinsa Corporation Receives GRAS Status For Its Branded Ingredient Cococin™ Freeze dried, coconut water solids deemed safe for use in foods and beverages
    • Press Release
      • Press Releases 2016
        • Sabinsa announces curcumin testing program to assure authenticity in campaign to eliminate adulteration with synthetics
        • Metabolic syndrome study on Sabinsa’s Curcumin C3 Complex® honored with university research of the year award
        • Sabinsa receives “No Questions” letter from US FDA on GRAS Status for LactoSpore®
        • Sabinsa to feature LactoSpore® at New York society of Cosmetic Chemists Suppliers’ Day – Booth # 1246
        • Sabinsa to feature LactoSpore®, Sabeet® and Curcumin uC3 Clear™ at Vitafoods – Stand #: H21
        • Sabinsa on wheels science summit in Germany hosts key customers and industry experts
        • Sabinsa founder Dr. Muhammed Majeed honored as Industry Legend
        • Sabinsa founder Dr. Majeed honored with Global Innovation & Excellence Award for 110 patents, 15 patents recently added
        • Stability research published on Sabinsa’s LactoSpore® shelf stable probiotic for functional foods
        • Sabinsa publishes ForsLean® safety data in International Journal of Pharmacy & Pharmaceutical Research
        • Resveratrol and Sabinsa’s BioPerine® on mitochondrial capacity with exercise
        • European journal publishes article on Sami/Sabinsa oil control moisturizer safety and efficacy
        • Sabinsa corporation defends proprietary distinctiveness in its brand “Boswellin”
        • Sabinsa achieves significant canadian health claim on IBS for shelf stable probiotic LactoSpore®
        • Sami-Sabinsa recognized by Global Health & Pharma as the “BEST International Life Science Company” and “Most Innovative Inflammatory Condition Treatment”
        • Sabinsa’s parent company Sami Labs recognized for excellence in research and development
        • Sami-Sabinsa recognized for export excellence by karnataka government trade promotion centre
        • Sabinsa Europe and Healthspan Ltd. enter into Curcumin C3 Complex® supply agreement
        • Sami-Sabinsa sponsors ayurveda medical association national cancer treatment seminar: Ayurcan
        • Sabinsa Europe initiates legal proceedings against a former employee and a competitor, bioactives, for theft of customer database, financial data and proprietary sales information
        • New safety, stability and efficacy studies published on Sabinsa’s GRAS, shelf-stable probiotic LactoSpore®
        • Sabinsa receives approval for New Health Claims on Curcumin C3 Complex® and Curcumin C3 Reduct® in Canada
        • Sabinsa and Chemill Reach licensing agreement Sabinsa’s Tetrahydrocurcuminoids patent honored
        • Sabinsa’s Boswellin® super reported in Japanese study to show improvement in knee pain
        • US district court holds Aegle Bios liable for willful infringement of Sabinsa’s Tetrahydrocurcuminoid patent
        • Sabinsa’s VP scientific affairs Anurag Pande Ph.D. speaks at Nutraceutical and Functional Food Summit in Beijing
        • Nachurel ingredients agrees to consent judgment honoring Sabinsa’s Tetrahydrocurcuminoids patent
        • Sabinsa’s Curcumin C3 Complex® in combination with Omega-3s found to have synergistic effect
        • Sabinsa on Wheels science summit In Tokyo
        • Sabinsa’s VP scientific affairs Dr. Anurag Pande to present on LactoSpore® At 4th microbiome R&D and business collaboration forum
        • Sabinsa again honored with two pharmexcil awards noting excellence in patents and exports
        • Sabinsa to highlight recent published studies, new canadian health claims at Supplyside West
        • Sabinsa defends Tetrahydrocurcuminoids patent with legal action
      • Press Releases 2017
        • Sabinsa to launch Promond™ almond protein powder, give away new BioPerine® book at Supplyside West
        • Sabinsa granted US patent for synbiotic composition of LactoSpore® shelf stable probiotic and cranberry fibers
        • New patents granted to Sabinsa’s cosmetics division in US and EU
        • Sabinsa publishes scientific compendium on BioPerine® black pepper extract
        • Shaheen Majeed named Sabinsa President worldwide
        • Sabinsa successfully protects its Curcumin C3 Reduct® technology
        • Sabinsa’s Curcumin C3 Complex® with BioPerine® shows protective role in lipid profile modification in type 2 diabetes in published study
        • German trade court decides in Sabinsa’s favor in lawsuit against german based competitor for theft of proprietary information
        • Sabinsa takes action against Biotikon for synthetic curcumin adulteration
        • Sami-Sabinsa group opens 2nd continuous extraction facility to meet demand for Curcumin C3 Complex® and other extracts
        • Sabinsa’s Curcumin C3 Complex® and Aspirin Combination Researched in Groundbreaking Colorectal Cancer Study
        • Court orders olive lifesciences to pay sabinsa $2.2 million for willfull infringement
        • Sabinsa’s VP scientific affairs Dr. Pande featured in probiotics podcast providing details on LactoSpore®
        • Sabinsa granted US patent on LactoSpore® for IBS
        • Sabinsa’s Curcumin C3 Complex® studied for antioxidant effect in diabetes patients
        • Sabinsa’s DigeZyme® shows benefit for delayed onset muscle soreness in published study
      • Press Releases 2018
        • Sabinsa to Launch Shagandha™ USP Grade Ashwagandha at SupplySide West
        • Sami-Sabinsa Group Diversifies into Information Technology and Business Solutions With Expansion of Edkal Technologies to US
        • Research on Curcumin’s Positive Effects on Microbiome Published Sabinsa Supplied Curcumin C3 Complex® and BioPerine® to Researchers
        • Sabinsa’s Multi-Enzyme Complex DigeZyme® Demonstrated Efficacy in Management of Dyspeptic Symptoms with Functional Dyspepsia: Published Clinical Study
        • Sami–Sabinsa Founder and Sami Labs Honored With Multiple Awards by Associated Chambers of Commerce & Industry of India for Outstanding Nutraceuticals Industry Achievement
        • Dr. Muhammed Majeed Names Ms. Asha Ramesh CEO of Sabinsa USA
        • Sabinsa Announces Additions to U.S. Sales and R&D Staff
        • Sabinsa Announces The Appointment of Liz Smith as Marketing Director
        • Sabinsa’s Shelf Stable Probiotic LactoSpore® Found to Reverse Depression Symptoms in Patients Suffering From IBS According to Published Study
        • Sami-Sabinsa Honored By Pharmexcil For Export Excellence
        • Sabinsa’s Shelf Stable Probiotic LactoSpore® May Improve Cholesterol Levels, Study Suggests
        • Sami-Sabinsa Group FSMA Implementation Update: 14 Staff PCQI Certified
        • Sabinsa Opens Toronto Office to Support Canadian Customers and Market
        • Sabinsa Signs Memorandum of Understanding with Japan External Trade Organization at Summit With Prime Ministers of India and Japan
        • Sabinsa’s Nigellin™ Black Cumin Seed Extract Identified as a Potent Favorable Immunomodulation in Asthma Inflammation
        • Sami–Sabinsa Honored by Associated Chambers of Commerce & Industry of India for Beauty, Wellness & Personal Care
        • New Diabetic Research on Sabinsa’s Curcumin C3 Complex® and BioPerine® Combination Published
        • Sabinsa Honored with Two Prestigious Awards Acknowledging the Significance of the Company’s Cultivation and Reforestation Programs
        • Sabinsa Appoints Natalie Martinez Head of Cosmetics Sales for The Americas
        • Sabinsa parent company Sami Labs honored with outstanding export award
        • Sabinsa successfully protects its Curcumin C3 Reduct® technology
        • Tufts – Tohoku study on curcumin + piperine combination verifies Sabinsa’s research on synergistic properties
        • Sabinsa Worldwide President Shaheen Majeed Addressed Supply Chain Complexities at Engredea Trade Show
        • Sabinsa announces 10 year reforestation commitment to Pterocarpus marsupium cultivation
        • Sabinsa and Eurofins enter into global ID testing agreement for proprietary ingredient
        • Sabinsa focuses on science supporting popular ingredients at Engredea trade show
        • Sabinsa’s pTeroSol® Pterocarpus marsupium extract studied in published research for diabetic benefit
        • Dr. Umar Jan Named Sabinsa Europe Resident Director
        • Sabinsa Founder Dr. Muhammed Majeed Named NutraChampion
        • Sami-Sabinsa Group Scientists Publish Research on Flow Cytometry as an Effective Test Method to Assess Viable Spore Count in LactoSpore®
        • Study Utilizing Sabinsa’s Materials Determined Superiority of Pterostilbene Over Resveratrol in Reducing Blood Glucose Levels and Restoring Muscle Health in Diabetic Rats
        • Sami-Sabinsa’s Pterocarpus Marsupium Reforestation Program Named Industry Initiative of The Year Award Finalist
        • Sami-Sabinsa Group Acquires Exclusive Global Marketing Rights for European and USA Patents on Oroxylum indicium
        • Sami-Sabinsa Recognized For Export Achievement by Federation of Karnataka Chambers of Commerce & Industry
        • Sabinsa China to Exhibit and Sponsor Session on Digestive Health at Supplyside China
        • Sabinsa’s Legal Victory Over Olive Lifesciences for Patent Infringement Profiled in Prominent Law Journal
        • Body of science on Sabinsa’s LactoWise® and LactoCran® digestive health ingredients grows with publication of two new studies
        • Sami–Sabinsa Hyderabad Facility Receives NSF GMP Certification
      • Press Releases 2019
        • Published Study Reaffirms Function and Survival of Sabinsa’s LactoSpore®
        • Sabinsa Shagandha™ ashwagandha root extract 2.5% designed to meet USP monograph, verified by prominent botanical testing expert alkemist labs®
        • Sabinsa Named a Top New Jersey Company for Its Dynamic Growth
        • Sabinsa Issued New U.S. Patent for LactoSpore® Based upon Published Research Confirming Ability to Reverse Depression Symptoms in Patients Suffering from IBS
        • Sabinsa’s Pterostilbene in Silbinol® Subject of Published Study
        • Sabinsa’s Curcumin C3 Reduct® Self-Affirmed GRAS
        • Sabinsa achieves USP GMP audited status for three additional sites
        • Published analysis of curcumin research provides comprehensive overview
        • Sabinsa to feature new patent protected products at NYSCC suppliers’ day
        • Sabinsa’s manufacturing arm receives research funding from the Government of India
        • Sabinsa’s biotechnology site achieves USP GMP audited status
        • Sabinsa awarded new patents for ForsLean®: New scientific discoveries warrant energy balance claims
        • Sabinsa launches LactoSporin®: Novel probiotic metabolite for skin and hair
        • Sabinsa scientist Dr. Natarajan honored by IASTAM for nutraceutical product development
        • New Research Expands upon Use of Sabinsa’s Curcumin C3 Complex® as an Adjunct to Chemotherapy
        • Sabinsa’s Four Indian Manufacturing Sites Achieve FSSC 22000 Certification
        • Sabinsa’s Parent Dubbed Most Trusted Nutraceutical Company
        • Government of Karnataka State, India Recognizes the Sami- Sabinsa Group with Three Awards for Export Excellence
        • Research Finds Sabinsa’s Curcumin C3 Complex® in Combination with BioPerine® Effective for Non-Alcoholic Fatty Liver Disease
        • Sami-Sabinsa Honored with Multiple “Best of” Awards in New Delhi and Singapore
        • Sabinsa Founder Dr. Muhammed Majeed Publishes Book on Reductive Metabolites of Curcuminoids
        • Sabinsa to Feature Tinofolin® Nootropic, Livinol™ for Liver Health & Weight Control, and Starmeric™ Turmeric-Derived Prebiotic at Supplyside West
        • Pilot Study Published Examining Curcumin C3 Complex® and BioPerine® With Taurine as Treatment for Hepatocellular Carcinoma
        • Study Shows Inhibitory Effect of Curcumin C3 Complex® and BioPerine® Combination on Malignant Mesothelioma Cells
        • Sabinsa Opens Sales Office in Poland to Serve Eastern Europe
        • Sabinsa appoints Lori Diez Sales Manager – Texas
      • Press Release 2020
        • Research on Sabinsa’s Cosmeceutical LactoSporin® Showing Anti-Acne Benefits among the First Published Human Clinical Studies Examining a Probiotic Metabolite
        • Sabinsa Issues Cease & Desist Letter Regarding Mischaracterized Amla Extracts to Applied Food Sciences
        • Sabinsa Introduces LivLonga®, a New Patented Combination for Liver Support
        • Sabinsa Earns Non-Gmo Project Verification For Eleven Key Ingredients
        • Sabinsa’s Curcumin C3 Complex® with BioPerine® Shown to Improve Cytokine Level
        • Dr. Majeed Foundation Makes Significant Contributions to Combat COVID-19 in India, Including $1.32 Million to PM CARES Fund
        • Sabinsa Warns Industry Against Mischaracterized Amla Extracts
        • Research Review of Curcumin’s Immune Benefits by Sabinsa Founder Dr. Muhammed Majeed Published
        • Sabinsa’s pTeroWhite® Subject of Two New Published Studies Reporting Anti-Aging, Skin Brightening, and SPF Benefits
        • Sabinsa Publishes Study Evaluating Hair Health Serum in Trial of Adults Hair Thinning and Loss
        • Sabinsa Granted Patent on a Combination of the Company’s Ingredients for Hair Growth in Mexico
        • Sabinsa Expands IP Portfolio with Five New U.S. Patents, Two CII Awards for IP Portfolio, and Dr. Majeed Honored by IASTAM
        • Sabinsa’s Macumax® Formula Demonstrates Vision Health Benefits in Published Study
        • Sabinsa Founder Honored by ASSOCHAM for Lifetime Achievement
        • Sabinsa Founder Dr. Muhammed Majeed Publishes Fourth Book on Boswellia
        • Sabinsa Continues the Fight Against Adulterated Vitamin C in Food and Beverage Products by Alerting Regulatory Agencies
        • Sabinsa Providing Glyphosate Test Results with Ingredients
        • Sabinsa Granted Patent in Mexico on Boswellin® PS for Inflammation
        • Sabinsa Granted Three New Patents in Canada, Including uC3 Clear® Water Soluble Curcumin
        • Dr. Majeed Foundation Distributes 5,500 Rice Bags to Needy Communities in Karnataka, India
        • Sami-Sabinsa Group Celebrates Three Prestigious Awards From ASSOCHAM
        • Sabinsa to Feature Dispersible Curcumin and Functional GRAS Ingredients at Expo West
        • Sabinsa’s Parent Company Sami Labs Breaks Ground on $30 Million USD State-of-the-Art Production Facility in India
      • Press Release 2021
        • Sabinsa Cosmeceutical Ingredients COSMOS Approved: Cococin™, Saberry®, and Nigellin® Amber
        • Sabinsa Founder Dr. Muhammed Majeed Named Father of Indian Nutraceuticals Industry by ASSOCHAM
        • Sabinsa Reaches Intellectual Property Milestone with over 300 Patents Granted
        • New Research Published on Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient
        • Research Published on Sabinsa’s Curcumin C3 Complex® / BioPerine® Combination as Adjuvant Therapy in COVID-19 Patients
        • Sabinsa Top Scientist Gives Presentation to U.S. FDA
        • Court Orders Prakruti to Pay over $1 Million in Fees and Costs to Sabinsa as a Sanction for Discovery Abuses in Litigation
    • Sabinsa Earns Non-Gmo Project Verification For Eleven Key Ingredients
    • Sabinsa Publishes Study Evaluating Hair Health Serum in Trial of Adults Hair Thinning and Loss
    • Sabinsa Granted Patent on a Combination of the Company’s Ingredients for Hair Growth in Mexico
    • Sabinsa Cosmeceutical Ingredients COSMOS Approved: Cococin™, Saberry®, and Nigellin® Amber
    • Sabinsa Secures U.S. Patent For Cococin™ Ingredient
    • White Papers
      • The Nourishment Factor®: Cococin™
  • IP Rights
    • Patents
  • About Starmeric®
  • Home

Sitemap

  • About Starmeric™
  • IP Rights
    • Patents
  • Newsroom
    • Press release
  • About Sabinsa
  • Contact Us

About Sabinsa

Sabinsa is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.

Read More..

Headquarters

Sabinsa Corporation

20 Lake Drive 

East Windsor

NJ 08520, USA

 

Tel : +1 732 777 1111

Fax: +1 732 777 1443

info@sabinsa.com

Global Contact List

USAIndia
Utah, USAJapan
AustraliaPoland
BrasilKorea
CanadaSouth Africa
ChinaVietnam
Germany 

Contact us

    © 2023 Sabinsa. All Rights Reserved | Powered by Edkal Technologies | Privacy Policy | Sitemap | Terms of Use | Disclaimer

    ×

    Disclaimer

    US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

    EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.